The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case-Control Study.

MLA

Frydrychowicz, Magdalena, et al. “The Alteration of Circulating Invariant Natural Killer T, ΓδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case-Control Study.” Cells, vol. 13, no. 16, Aug. 2024. EBSCOhost, https://doi.org/10.3390/cells13161401.

APA

Frydrychowicz, M., Telec, M., Anioła, J., Kazmierski, R., Chowaniec, H., Dworacki, G., Wojtasz, I., Kozubski, W., & Łukasik, M. (2024). The Alteration of Circulating Invariant Natural Killer T, γδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case-Control Study. Cells, 13(16). https://doi.org/10.3390/cells13161401

Chicago

Frydrychowicz, Magdalena, Magdalena Telec, Jacek Anioła, Radosław Kazmierski, Hanna Chowaniec, Grzegorz Dworacki, Izabela Wojtasz, Wojciech Kozubski, and Maria Łukasik. 2024. “The Alteration of Circulating Invariant Natural Killer T, ΓδT, and Natural Killer Cells after Ischemic Stroke in Relation to Clinical Outcomes: A Prospective Case-Control Study.” Cells 13 (16). doi:10.3390/cells13161401.